Advertisement · 728 × 90

Posts by Lesley Goodburn

Preview
New Evidence Backs Hologic’s AI-Powered Mammography Technology for Detecting Challenging Cancers

www.biospace.com/press-releas...

23 hours ago 0 0 0 0
Preview
When Hard Doesn’t Mean Malignant: A Benign Axillary Finding in Lobular Carcinoma A 50-year-old premenopausal woman presented with an abnormal screening mammogram, which led to the diagnosis of grade 2 invasive lobular carcinoma of the left breast with axillary lymph node metastase...

www.cureus.com/articles/447...

2 days ago 0 0 0 0

www.usnews.com/news/health-...

2 days ago 0 0 0 0

www.usnews.com/news/health-...

2 days ago 1 0 0 0
Preview
Pancreatic cancer mRNA vaccine shows lasting results in an early trial Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later.

www.nbcnews.com/health/cance...

2 days ago 0 0 0 0

www.medrxiv.org/content/10.6...

2 days ago 0 0 0 0

So many pieces of research are close to breakthrough x

2 days ago 1 0 0 0
Trop-2.2–Directed Radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a Pancreatic Cancer Model AbstractPurpose:. Trophoblast cell surface antigen-2 (Trop-2) is a membrane-bound antigen associated with cancer invasiveness and poorer patient outcomes. Delivery of therapeutics via Trop-2 targeting...

aacrjournals.org/clincancerre...

2 days ago 0 0 0 0
Advertisement

There are a very few patients who do but they are few and very far between

2 days ago 1 0 0 0
RAGE signaling inhibition prevents the malignant phenotypes of pancreatic ductal adenocarcinoma cells - Scientific Reports Receptor for advanced glycation end-products (RAGE) is implicated in immune and inflammatory diseases as well as the malignant phenotypes of cancer. Blocking RAGE signaling is thought to reduce its im...

www.nature.com/articles/s41...

2 days ago 0 0 0 0
From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped | Memorial Sloan Kettering Cancer Center An MSK study reveals new details about how pancreatic cells carrying oncogenic mutations transition from benign to malignant — shining new light on the ecosystems that supports emerging tumors.

www.mskcc.org/news/from-be...

2 days ago 0 0 0 0
Preview
Four rising stars shaping the future of cancer research Meet the creative minds that aim to improve cancer detection and treatment.

www.nature.com/articles/d41...

2 days ago 0 0 0 0
Preview
Cancer research extends beyond the lab for public health student When Subin Kim learned she had been selected as one of just 20 early-career scientists nationwide to participate in the 11th Annual American Association for Cancer Research (AACR) Early-Career Hill Da...

uknow.uky.edu/research/can...

2 days ago 0 0 0 0
Preview
Prince Philip pancreatic cancer: The risks of developing the disease Prince Philip quietly lived with pancreatic cancer for nearly eight years before his death, a condition that is notoriously hard to detect and has one of the lowest survival rates of any cancer.

www.dailymail.co.uk/health/artic...

2 days ago 0 0 1 0
Preview
Four rising stars shaping the future of cancer research Meet the creative minds that aim to improve cancer detection and treatment.

www.nature.com/articles/d41...

2 days ago 0 0 0 0
Preview
Breakthrough in pancreatic cancer treatment with successful first histotripsy trials A pioneering medical team in Hong Kong has successfully completed the first two clinical trial cases using histotripsy to treat pancreatic cancer, offering new hope for patients with one of the most c...

www.thestandard.com.hk/news/article...

2 days ago 0 0 0 0
1H NMR-based serum metabolomics identifies discriminatory metabolic signatures associated with pancreatic cancer - Scientific Reports Pancreatic cancer (PC) remains one of the most aggressive malignancies, characterized by late-stage diagnosis and poor prognosis. Identifying reliable biomarkers for early detection is crucial to impr...

www.nature.com/articles/s41...

2 days ago 0 0 0 0
Preview
Theriva to present VCN-01 pancreatic cancer trial data at AACR By Investing.com Theriva to present VCN-01 pancreatic cancer trial data at AACR

au.investing.com/news/company...

2 days ago 0 0 0 0
Advertisement
PressReader.com - Digital Newspaper & Magazine Subscriptions Digital newsstand featuring 7000+ of the world’s most popular newspapers & magazines. Enjoy unlimited reading on up to 5 devices with 7-day free trial.

www.pressreader.com/uk/sunderlan...

2 days ago 0 0 0 0
Preview
Most patients with advanced cancer still not receiving genomic testing, study finds | Managed Healthcare Executive Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

www.managedhealthcareexecutive.com/view/most-pa...

2 days ago 0 0 0 0
Central Ohio advocates join national movement to end pancreatic cancer
Central Ohio advocates join national movement to end pancreatic cancer YouTube video by WBNS 10TV

www.youtube.com/watch?v=cwUj...

2 days ago 0 0 0 0
Preview
AIM Plans Pivotal Phase 3 Trial for Pancreatic Cancer In late-stage pancreatic ductal adenocarcinoma, rintatolimod (Ampligen) has generated early clinical signals across multiple settings: a Dutch named-patient program of 82 monotherapy recipients report...

www.clinicaltrialvanguard.com/news/aim-pla...

2 days ago 0 0 0 0
Checking your browser - reCAPTCHA

pubmed.ncbi.nlm.nih.gov/41995512/?ut...

3 days ago 0 0 0 0
Preview
Patient-Centered Approaches Are Vital for Navigating Treatment Decisions in Pancreatic Cancer | OncLive Dallas Gallagher, DNP, FNP-C, AOCNP, discusses individualized chemotherapy selection and the importance of a "person-first" approach to pancreatic cancer care.

www.onclive.com/view/patient...

3 days ago 0 0 0 0
Preview
A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment "I do think it's a revolution," said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.

www.statnews.com/2026/04/17/r...

3 days ago 0 0 0 0
Preview
ADC Improves Invasive Disease-Free Survival in Breast Cancer: Research Recap The phase 3 DESTINY-Breast05 trial showed that trastuzumab deruxtecan (Enhertu) significantly improved invasive disease–free survival vs trastuzumab emtansine (Kadcyla) in HER2-positive early breast c...

www.oncologynewscentral.com/breast-cance...

4 days ago 0 0 0 0
Preview
Gifts in Wills Lead to Life-Changing Cancer Research - University of Birmingham Gifts left in wills in the past are helping to shape the cancer research making a difference to patients today.

www.birmingham.ac.uk/news/2026/gi...

4 days ago 0 0 0 0
Advertisement
Preview
Tributes paid to 'inspirational' teacher who died after short cancer battle A SCHOOL in Kingswinford has paid tribute to a much-loved teacher who supported “thousands of students and families” over more than two decades.

www.dudleynews.co.uk/news/2601450...

1 week ago 0 0 0 0
Preview
Pancreatic Cancer charity supporting training for GHA surgeons

www.gbc.gi/news/pancrea...

1 week ago 0 0 0 0
Preview
Mother's memory inspires Bedworth son's 30km challenge Dave Pullin is taking part in a 30km a month activity challenge after his mum died from cancer.

www.bbc.co.uk/news/article...

1 week ago 0 0 0 0